本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

方舟生物醫藥

28.80
+0.0000
成交量:- -
成交額:68.83萬
市值:8.49億
市盈率:-57.85
高:28.80
開:28.80
低:28.80
收:28.80
資料載入中...
2024/06/19

SEC問詢函

Form CORRESP - Correspondence
2024/06/06

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/04/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/05

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/04/04

重要事件披露

Form 8-K - Current report
2024/04/03

重要事件披露

Form 8-K - Current report
2024/04/03

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2024/02/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/31

重要事件披露

Form 8-K - Current report